Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (GB:0Q1G)
LSE:0Q1G
Holding GB:0Q1G?
Track your performance easily
See the Price Targets and Ratings of:
0Q1G Analyst Ratings
Strong Buy
18 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0Q1G Stock 12 Month Forecast
Average Price Target
CHF892.37
▲(65.25% Upside)
| Highest Price TargetCHF978.12 | Average Price TargetCHF892.37 | Lowest Price TargetCHF728.06 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Assigned
09/23/24
Bank of America Securities
Assigned
09/23/24
Wells Fargo
Assigned
09/20/24
Deutsche Bank
Reiterated
09/20/24
BMO Capital
Reiterated
09/13/24
J.P. Morgan
Reiterated
09/13/24
Evercore ISI
Assigned
09/11/24
Berenberg Bank
Reiterated
09/06/24
TD Cowen
Assigned
09/06/24
Jefferies
CHF893.07→CHF946.65
Buy
75.31%
Upside
Assigned
08/28/24
Eli Lilly & Co: Strategic Pricing and Market Expansion Fuel Buy Rating
Morgan Stanley
CHF940.7
Buy
74.20%
Upside
Reiterated
08/27/24
Vial volumes could offset Lilly's Zepbound price pressure, says Morgan StanleyVial volumes could offset Lilly's Zepbound price pressure, says Morgan Stanley
Leerink Partners
―
Buy
―
Reiterated
08/20/24
Eli Lilly's Tirzepatide Shows Promise in Preventing Type 2 Diabetes, Earns Buy Rating
Guggenheim
CHF751.88→CHF876.06
Buy
62.23%
Upside
Reiterated
08/16/24
Eli Lilly price target raised to $1,030 from $884 at GuggenheimEli Lilly price target raised to $1,030 from $884 at Guggenheim
DBS
CHF901.57
Buy
66.96%
Upside
Reiterated
08/13/24
Eli Lilly & Co: A Strong Buy on Robust Pipeline and Market Leadership
Best Analysts Covering Eli Lilly & Co
Which Analyst Should I Follow If I Want to Buy GB:0Q1G and Sell After:
1 Month
xxx
Success Rate
13/17 ratings generated profit
Average Return
+6.84%
assigned a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 76.47% of your transactions generating a profit, with an average return of +6.84% per trade.
3 Months
xxx
Success Rate
16/17 ratings generated profit
Average Return
+15.46%
assigned a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 94.12% of your transactions generating a profit, with an average return of +15.46% per trade.
1 Year
Success Rate
29/29 ratings generated profit
Average Return
+58.51%
reiterated a buy rating last month
Copying Terence Flynn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +58.51% per trade.
2 Years
xxx
Success Rate
29/29 ratings generated profit
Average Return
+104.11%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +104.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0Q1G Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
0
0
0
0
0
Buy
63
63
61
70
63
Hold
6
5
11
11
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
69
68
72
81
76
Each month's total comprises the sum of three months' worth of ratings.
0Q1G Financial Forecast
0Q1G Stock Forecast FAQ
What is GB:0Q1G’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is CHF892.37.
What is GB:0Q1G’s upside potential, based on the analysts’ average price target?
Eli Lilly & Co has 65.25% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Eli Lilly & Co a Buy, Sell or Hold?
Eli Lilly & Co has a consensus rating of Strong Buy, which is based on 18 buy ratings, 2 hold ratings and 0 sell ratings.
What is Eli Lilly & Co’s share price target?
The average share price target for Eli Lilly & Co is CHF892.37. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF978.12 ,and the lowest forecast is CHF728.06. The average share price target represents 65.25% Increase from the current price of CHF540.
The highest analyst share price target is CHF978.12 ,and the lowest forecast is CHF728.06. The average share price target represents 65.25% Increase from the current price of CHF540.
What do analysts say about Eli Lilly & Co?
Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of Eli Lilly & Co?
To buy shares of GB:0Q1G, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.